UK politicians and health experts have welcomed the interim trial results for the Pfizer/BioNTech COVID-19 vaccine candidate but they are counseling caution and playing down suggestions that “things could return to normal” by spring 2021.
The results showed the vaccine had an efficacy rate of more than 90%. Health Secretary Matt Hancock described the news...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?